The American Journal of Managed Care2u
Discussing Real-World Ruxolitinib and Corticosteroid Treatment Patterns in Patients with cGVHD
Sergio A. Giralt, MD, discusses how he selects patients with chronic graft-vs-host disease (cGVHD) for treatment with ...
The American Journal of Managed Care2u
Main Conference Takeaways Regarding cGVHD Management
Sergio A. Giralt, MD, discusses the key results from recent chronic graft-vs-host disease (cGVHD) research presented at ASH ...
The American Journal of Managed Care2u
The Role of Posttransplant Cyclophosphamide in Patients With cGVHD
Sergio A. Giralt, MD, discusses how he uses cyclophosphamide to treat patients with chronic graft-vs-host disease (cGVHD), ...
The American Journal of Managed Care1u
Ethnic Disparities Identified in Colorectal Cancer Diagnoses, Study Finds
New research examines how ethnicity impacts colorectal cancer diagnosis, early-onset colorectal cancer (CRC) prevalence, and ...
The American Journal of Managed Care2u
Glaucoma Can Go Years Undetected Due to Few Noticeable Symptoms
Glaucoma can cause damage to the optic nerve if left untreated, making frequent eye appointments vital for catching it ...
The American Journal of Managed Care4u
MRD Negativity: A "Robust" Predictor of Survival Outcomes in MM
This meta-analysis sheds more light on the beneficial impact of multiple melanoma (MM) treatments and the predictive value of ...
The American Journal of Managed Care1u
Expanding Bispecific Therapies to Community Settings: Challenges and Innovations
Amrita Krishnan, MD, discusses how an ASH 2024 abstract from Sylvester Comprehensive Cancer Center suggests the potential of tocilizumab prophylaxis to mitigate cytokine release syndrome (CRS) in ...
The American Journal of Managed Care1u
Proactive CRS Management: The Role of Tocilizumab and Beyond
Amrita Krishnan, MD, discusses how data from ASH 2024 highlight the critical role of intravenous immunoglobulin (IVIG) treatment in preventing infections in patients receiving teclistamab, shares her ...
The American Journal of Managed Care2u
Exploring Combination Therapy with Ibrutinib and Rituximab in cGVHD
Sergio A. Giralt, MD, discusses how rituximab plays a key role in treating chronic graft-vs-host disease. It is often used in combination with ibrutinib to enhance therapeutic outcomes. He reviews the ...
The American Journal of Managed Care5u
Impact of Recurrent C Difficile Infection on Costs and Patient Quality of Life
The panelist discusses how recurrent Clostridioides difficile infection significantly increases health care costs through prolonged hospitalizations, complex treatments, and elevated medical resource ...